Brief: Enanta Pharmaceuticals Reports Financial Results For Fiscal Fourth Quarter And Full Year

Enanta Pharmaceuticals

21/11/2022 21:07

Nov 21 (Reuters) - Enanta Pharmaceuticals Inc  ENTA.O :
    * ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS
FISCAL
FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2022 WITH WEBCAST
AND CONFERENCE CALL TODAY AT 4:30 P.M. ET
    * TOTAL REVENUE OF $20.3 MILLION FOR THREE MONTHS ENDED
SEPTEMBER
30, 2022
    * QTRLY LOSS PER SHARE $1.27
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$278.5
MILLION AT SEPTEMBER 30, 2022
    * Q4 EARNINGS PER SHARE VIEW $-1.35, REVENUE VIEW $22.9
MILLION --
REFINITIV IBES DATA
    * ENANTA -SEES CASH RUNWAY TO BE SUFFICIENT TO MEET
ANTICIPATED
CASH REQUIREMENTS OF EXISTING BUSINESS & DEVELOPMENT PROGRAMS
INTO Q4 OF FISCAL 2024

Source text for Eikon:  ID:nBw3TgCHYa 
Further company coverage:  ENTA.O 
 ((Reuters.Briefs@thomsonreuters.com;))